title: Development of a multiplex autoantibody test for detection of lung cancer.
abstract: Lung cancer is the leading cause of cancer-related deaths for both men and women. Early diagnosis of lung cancer has a 5-year survival rate of 48.8%, however, nearly 35% of stage I patients relapses after surgical resection, thus portending a poor prognosis. Therefore, detecting lung cancer in early stage and further identifying the high-risk patients would allow the opportunity to provide adjuvant therapy and possibly increase survival. There is considerable evidence that the immune system produces an autoantibody response to neoplastic cells. The detection of such autoantibodies has been shown to have diagnostic and prognostic value. Here we took advantage of the high-throughput Luminex technique to multiplex a total of 14 tumor-associated autoantigens to detect the autoantibody from the patients sera. The 14 antigens were expressed by in vitro transcription/translation system with HaloTag at N-terminus. The fusion proteins were then covalently immobilized onto the Luminex microspheres conjugated by the halo-link ligand, thus eliminating the protein purification procedure. Sera samples from cancer patients and healthy controls were interacted with the microsphere-antigen complex to measure the autoantibodies. We have developed a quick multiplex detection system for measuring autoantibody signature from patient sera with minimal cross-reaction. A panel of seven autoantibody biomarkers has generated an AUC>80% in distinguishing the lung cancers from healthy controls. This study is the first report by combining Luminex platform and HaloTag technology to detect humoral immune response in cancer patients. Due to the flexibility of the Luminex technology, this approach can be applied to others conditions such as infectious, neurological, and metabolic diseases. One can envision that this multiplex Luminex system as well as the panel of seven biomarkers could be used to screen the high-risk population with subsequent CT test based on the blood test result.
authors.affiliation: Center for Molecular Medicine, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, P. R. China.
authors.forename: Jing
authors.initials: J
authors.lastname: Jia
authors.affiliation: Center for Molecular Medicine, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, P. R. China.
authors.forename: Wenzhe
authors.initials: W
authors.lastname: Wang
authors.affiliation: Hangzhou First People's Hospital, Hangzhou, Zhejiang, P. R. China.
authors.forename: Wen
authors.initials: W
authors.lastname: Meng
authors.affiliation: Center for Molecular Medicine, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, P. R. China.
authors.forename: Mingjian
authors.initials: M
authors.lastname: Ding
authors.affiliation: Institute of Lung Cancer, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, P. R. China; Hangzhou First People's Hospital, Hangzhou, Zhejiang, P. R. China.
authors.forename: Shenglin
authors.initials: S
authors.lastname: Ma
authors.affiliation: Center for Molecular Medicine, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, P. R. China; Institute of Lung Cancer, Zhejiang Academy of Medical Sciences, Hangzhou, Zhejiang, P. R. China.
authors.forename: Xiaoju
authors.initials: X
authors.lastname: Wang
mesh_terms: D000328:Adult; D000368:Aged; D001323:Autoantibodies / Q000097:blood / Q000276:immunology*; D016022:Case-Control Studies; D003429:Cross Reactions / Q000276:immunology; D055088:Early Detection of Cancer / Q000379:methods*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008024:Ligands; D008175:Lung Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D012372:ROC Curve; D015203:Reproducibility of Results
chemical_list: D001323:Autoantibodies; D008024:Ligands
references.citation: Cancer Cell. 2005 May;7(5):411-23
references.pmid: 15894262
references.citation: Int J Oncol. 2013 Jan;42(1):93-100
references.pmid: 23165420
references.citation: Cancer. 2004 Jul 1;101(1):3-27
references.pmid: 15221985
references.citation: Lung Cancer. 2003 Mar;39(3):297-301
references.pmid: 12609568
references.citation: Cancer Lett. 2006 May 8;236(1):64-71
references.pmid: 15992994
references.citation: Methods. 2006 Apr;38(4):317-23
references.pmid: 16481199
references.citation: Zhongguo Fei Ai Za Zhi. 2010 Jul;13(7):706-12
references.pmid: 20673487
references.citation: Clin Chem. 2010 Feb;56(2):314-8
references.pmid: 20022982
references.citation: Nat Rev Cancer. 2006 Jan;6(1):24-37
references.pmid: 16397525
references.citation: Biomark Med. 2012 Oct;6(5):597-612
references.pmid: 23075238
references.citation: Thorax. 2008 Mar;63(3):228-33
references.pmid: 17932110
references.citation: BMC Cancer. 2010 May 26;10:234
references.pmid: 20504322
references.citation: Respir Res. 2010 Feb 10;11:18
references.pmid: 20146812
references.citation: Mol Cell Proteomics. 2006 Oct;5(10):1745-59
references.pmid: 16733262
references.citation: Clin Chim Acta. 2011 Jul 15;412(15-16):1417-22
references.pmid: 21536019
references.citation: Autoimmun Rev. 2011 Apr;10(6):331-5
references.pmid: 21167321
references.citation: J Natl Cancer Inst. 2009 Jan 7;101(1):11-3
references.pmid: 19116384
references.citation: J Clin Invest. 2001 Nov;108(10):1411-5
references.pmid: 11714730
references.citation: ACS Chem Biol. 2008 Jun 20;3(6):373-82
references.pmid: 18533659
references.citation: Oncol Rep. 2000 May-Jun;7(3):669-74
references.pmid: 10767388
references.citation: CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29
references.pmid: 22237781
references.citation: Cancer Res. 2007 Dec 15;67(24):12000-6
references.pmid: 18089831
references.citation: J Int Med Res. 2010 May-Jun;38(3):737-49
references.pmid: 20819411
references.citation: Ann Oncol. 2011 Feb;22(2):383-9
references.pmid: 20675559
references.citation: Biochem Biophys Res Commun. 2012 Jul 6;423(3):613-9
references.pmid: 22713465
references.citation: Cancer Res. 2007 Apr 1;67(7):3461-7
references.pmid: 17409457
references.citation: Am J Clin Pathol. 2002 Apr;117(4):589-96
references.pmid: 11939734
references.citation: Biomarkers. 2010 Mar;15(2):128-34
references.pmid: 19839718
references.citation: PLoS One. 2010 Dec 07;5(12):e15003
references.pmid: 21170350
references.citation: Biochim Biophys Acta. 2006 Apr;1762(4):398-403
references.pmid: 16483750
references.citation: J Clin Oncol. 2008 Nov 1;26(31):5060-6
references.pmid: 18794547
references.citation: Lung Cancer. 2005 May;48(2):217-21
references.pmid: 15829321
references.citation: Clin Cancer Res. 2010 Jul 1;16(13):3452-62
references.pmid: 20570928
references.citation: FEBS Lett. 2005 May 23;579(13):2873-7
references.pmid: 15876430
references.citation: BMC Res Notes. 2011 Sep 09;4:340
references.pmid: 21906296
references.citation: J Thorac Oncol. 2006 Jul;1(6):513-9
references.pmid: 17409910
references.citation: Cancer. 2001 Jan 1;91(1):178-88
references.pmid: 11148575